CERo Therapeutics Inc. (CERO)
NASDAQ: CERO
· Real-Time Price · USD
20.08
13.21 (192.37%)
At close: Jun 17, 2025, 3:59 PM
192.37% (1D)
| Bid | 17.02 |
| Market Cap | 10.36M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -13.9M |
| EPS (ttm) | -488.69 |
| PE Ratio (ttm) | -0.04 |
| Forward PE | -0.28 |
| Analyst | Hold |
| Ask | 17.2 |
| Volume | 56,845,158 |
| Avg. Volume (20D) | 101,355 |
| Open | 10.54 |
| Previous Close | 6.87 |
| Day's Range | 10.35 - 26.99 |
| 52-Week Range | 6.71 - 896.00 |
| Beta | 0.43 |
About CERO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CERO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CERO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 day ago
CERo Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
1 month ago
+38.84%
CERo Therapeutics Holdings shares are trading higher after the company announced the key clinical trial site location for its Phase 1 CER-1236 trial.
